-+ 0.00%
-+ 0.00%
-+ 0.00%

Wedbush Reiterates Outperform on Zura Bio, Maintains $15 Price Target

Benzinga·07/01/2026 13:56:15
Listen to the news
Wedbush analyst Martin Fan reiterates Zura Bio (NASDAQ:ZURA) with a Outperform and maintains $15 price target.